GHRH + GHRP combined in a single vial. Pairs Tesamorelin (a GHRH analog) with Ipamorelin (a selective GH secretagogue) in a single combo vial — pre-paired for synergistic GH axis and metabolic research.
Key Research Areas
GH axisPulsatile releaseMetabolic researchBody composition
Molecular Information
| Dosage | 12mg/2mg per vial |
| Purity | 99%+ (HPLC & MS Verified) |
| Format | Lyophilized powder |
| Storage | Store at -20°C. Stable at room temperature for short-term shipping. |
| Reconstitution | Bacteriostatic water (for research use only) |
| Verification | NFC Blockchain Tag included |
Tesamorelin + Ipamorelin — Combo Vial is a research compound with a growing body of published literature examining its biological activity and mechanisms of action. The research summaries below are derived from publicly available peer-reviewed studies and are provided for informational purposes only.
Research Focus Areas
GH axisPulsatile releaseMetabolic researchBody composition
Published research on Tesamorelin + Ipamorelin — Combo Vial spans multiple model systems and research frameworks. Studies have examined mechanisms at the molecular, cellular, and systemic levels. Researchers are encouraged to access primary literature through PubMed and peer-reviewed databases.
Research Disclaimer: The research summaries provided are for informational purposes only and are based on publicly available scientific literature. We do not make medical or therapeutic claims. These statements have not been evaluated by the FDA.
Every batch of Tesamorelin + Ipamorelin — Combo Vial is independently tested and shipped with a Certificate of Analysis documenting purity, identity, batch number, and testing methodology.
Testing Specifications
| Testing Method | HPLC + Mass Spectrometry |
| Purity Standard | 99%+ |
| Lab | Third-party independent laboratory (USA 🇺🇸) |
